Antimicrobial Efficacy of Quercetin against Biofilm Production by Staphylococcus Aureus
DOI:
https://doi.org/10.23851/mjs.v35i3.1367Keywords:
Staphylococcus aureus, Multidrug-resistant microbes, Anti-biofilm activity, Biofilm, QuercetinAbstract
Background: The bad administration of antibiotics represents a worldwide health issue as it leads to the emergence of multidrug-resistant microbes including Staphylococcus aureus, which represents a significant challenge for public health since it increases its ability to cause potentially fatal infections. Objective: This study aims to reduce the bacterium’s ability to form biofilms and antibiotic resistance. Methods: Thirty Staphylococcus aureus isolates were isolated from different clinical samples in Baghdad city and their ability to form biofilm was tested using the Microtiter Plate method. Out of 30 isolates, eight strong biofilm producer isolates were further investigated for their antimicrobial activity and biofilm formation with the impact of quercetin. Results: The results showed the ability of quercetin to inhibit bacteria and had an antibiofilm activity that was determined through investigation of the minimal inhibitory concentration by taking different concentrations. The anti-biofilm activity of quercetin was determined for the eight isolates and the results showed that biofilm formation was reduced by 100% using quercetin at a concentration of 3.1 mg/ml. Conclusions: Quercetin represents a suitable alternative to synthetic antimicrobials with the increased rate of drug-resistant bacteria among clinical samples with highly effective ability as anti-biofilm formation among strong biofilm producers of S. aureus.
Downloads
References
L. Yitayeh, A. Gize, M. Kassa, M. Neway, A. Afework, M. Kibret, and D. Resistance, "Antibiogram profiles of bacteria isolated from different body site infections among patients admitted to gamby teaching general hospital," Infection and Drug Resistance, vol. 14, pp. 2225-2232, 2021.
L. G. Harris, S. Foster, and R. G. Richards, "An introduction to Staphylococcus aureus and techniques for identifying and quantifying S. aureus adhesins in relation to adhesion to biomaterials: Review," eCM (European Cells and Materials), vol. 4, no. 3, pp. 100-120, 2002.
A. Y. Kwok and A. W. Chow, "Phylogenetic study of Staphylococcus and Macrococcus species based on partial hsp60 gene sequences," International Journal of Systematic and Evolutionary Microbiology, vol. 53, no. 1, pp. 87-92, 2003.
V. F. Marques, H. A. Santos, T. H. Santos, D. A. Melo, S. M. Coelho, I. S. Coelho, and M. Souza, "Expression of icaA and icaD genes in biofilm formation in Staphylococcus aureus isolates from bovine subclinical mastitis," Pesquisa Veterinária Brasileira, vol. 41, no. 3, pp. 1-7, 2021.
A. Farah, O. B. Abdeljelil, W. Jomaa, K. B. Hamda, and F. J. Maatouk, "Infective endocarditis Staphylococcus aureus versus other pathogens," Archives of Cardiovascular Diseases Supplements, vol. 12, no. 1, p. 98, 2020.
K. Tam and V. Torres, "Staphylococcus aureus secreted toxins and extracellular enzymes," Microbiology Spectrum, vol. 7, no. 2, p. 7.2.16, 2020.
E. O'Neill, C. Pozzi, P. Houston, D. Smyth, H. Humphreys, D. A. Robinson, and J. P. O'Gara, "Association between methicillin susceptibility and biofilm regulation in Staphylococcus aureus isolates from device-related infections," Journal of Clinical Microbiology, vol. 45, no. 5, pp. 1379-1388, 2007.
I. E. Alsaimary, "Comparative molecular analysis of Meca, Sea, and Seb genes in methicillin-resistant Staphylococcus Aureus (MRSA)," Journal of Clinical & Biomedical Research, 2020.
J. A. Freiberg, Y. Le Breton, J. M. Harro, D. L. Allison, K. S. McIver, and M. E. Shirtliff, "The arginine deiminase pathway impacts antibiotic tolerance during biofilm-mediated Streptococcus pyogenes infections," mBio, vol. 11, no. 4, e00919-00920, 2020.
K. M. Craft, J. M. Nguyen, L. J. Berg, and S. D. Townsend, "Methicillin-resistant Staphylococcus aureus (MRSA): Antibiotic-resistance and the biofilm phenotype," Journal of Medicinal Chemistry, vol. 62, no. 8, pp. 1231-1241, 2019.
P. Saxena, Y. Joshi, K. Rawat, and R. Bisht, "Biofilms: Architecture, resistance, quorum sensing and control mechanisms," Indian Journal of Microbiology, vol. 59, no. 1, pp. 3-12, 2020.
M. E. A. Bissong and C. N. Ateba, "Genotypic and phenotypic evaluation of biofilm production and antimicrobial resistance in Staphylococcus aureus isolated from milk, North West Province, South Africa," Antibiotics, vol. 9, no. 4, p. 156, 2020.
F. J. Osonga, A. Akgul, R. M. Miller, G. B. Eshun, I. Yazgan, and O. A. Sadik, "Antimicrobial activity of a new class of phosphorylated and modified flavonoids," ACS Omega, vol. 4, no. 7, pp. 12,865-12,871, 2020.
M. Rai, S. Zacchino, and M. Derita, Essential Oils and Nanotechnology for Treatment of Microbial Diseases. CRC Press, 2017.
T. L. Nguyen and D. Bhattacharya, "Antimicrobial activity of quercetin: An approach to its mechanistic principle," Molecules, vol. 27, no. 8, pp. 2-13, 2022.
V. Oliveira, E. Carraro, M. Auler, and N. Khalil, "Quercetin and rutin as potential agents antifungal against Cryptococcus spp.," Brazilian Journal of Biology, vol. 76, no. 4, pp. 1029-1034, 2016.
J.-H. Lee, J.-H. Park, H. S. Cho, S. W. Joo, M. H. Cho, and J. Lee, "Anti-biofilm activities of quercetin and tannic acid against Staphylococcus aureus," Biofouling, vol. 29, no. 5, pp. 491-499, 2013.
S. Archana and J. Abraham, "Comparative analysis of antimicrobial activity of leaf extracts from fresh green tea, commercial green tea and black tea on pathogens," Journal of Applied Pharmaceutical Science, vol. 1, no. 8, pp. 149-52, 2011.
A. Ahmad, M. Kaleem, Z. Ahmed, and H. Shafiq, "Therapeutic potential of flavonoids and their mechanism of action against microbial and viral infections," Food Research International, vol. 77, no. 2, pp. 221-235, 2015.
H. Yang, K. Li, H. Yan, S. Liu, Y. Wang, and C. Huang, "High-performance therapeutic quercetin-doped adhesive for adhesive-dentin interfaces," Scientific Reports, vol. 7, no. 1, pp. 1-11, 2017.
H. Hooda, P. Singh, and S. Bajpai, "Effect of quercetin-impregnated silver nanoparticles on growth of some clinical pathogens," Materials Today: Proceedings, vol. 31, pp. 625-630, 2020.
J. Allkja, F. van Charante, J. Aizawa, I. Reigada, C. Guarch-Pérez, J. A. Vazquez-Rodriguez, P. Cos, T. Coenye, A. Fallarero, S. A. J. Zaat, A. Felici, L. Ferrari, N. F. Azevedo, A. E. Parker, and D. M. Goeres, "Interlaboratory study for the evaluation of three microtiter plate-based biofilm quantification methods," Scientific Reports, vol. 11, no. 1, pp. 1-10, 2021.
D. Yang, T. Wang, M. Long, and P. Li, "Quercetin: Its main pharmacological activity and potential application in clinical medicine," Oxidative Medicine and Cellular Longevity, vol. 20, pp. 1-13, 2020.
Z. He, X. Zhang, Z. Song, L. Li, H. Chang, S. Li, and W. Zhou, "Quercetin inhibits virulence properties of Porphyromonas gingivalis in periodontal disease," Scientific Reports, vol. 10, no. 1, pp. 1-13, 2020.
A. Pal and A. Tripathi, "Demonstration of bactericidal and synergistic activity of quercetin with meropenem among pathogenic carbapenem-resistant Escherichia coli and Klebsiella pneumoniae," Microbial Pathogenesis, vol. 143, pp. 1-8, 2020.
Downloads
Key Dates
Received
Revised
Accepted
Published
Data Availability Statement
Data is available in the article.
Issue
Section
License
Copyright (c) 2024 Rayhana S. Najim, Mohsen Hashem Risan, Dhafar Najim Al-Ugaili
This work is licensed under a Creative Commons Attribution 4.0 International License.
(Starting May 5, 2024) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.